S3336 — Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical manufacturers.

S3336 — Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical manufacturers. · Informed CitizenryThis bill amends the Drug Utilization Review Board's regulations to require public members to disclose any financial interests or benefits received from pharmaceutical manufacturers. At the time of…Open in Informed Citizenry